IL-10 dampens TNF/inducible nitric oxide synthase-producing dendritic cell-mediated pathogenicity during parasitic infection

Journal of Immunology

Volumn 182, Issue 2, 2009, Pages 1107-1118

  Guilliams, Martin ^a,b   Movahedi, Kiavash ^a,b   Bosschaerts, Tom ^a,b   Vandendriessche, Thierry ^a,c   Chuah, Marinee Khim ^a,c   Hérin, Michel ^d   Acosta Sanchez, Abel ^a,c   Ma, Ling ^a,c   Moser, Muriel ^e   Van Ginderachter, Jo A ^a,b   Brys, Lea ^a,b   De Baetselier, Patrick ^a,b   Beschin, Alain ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY OF NAMUR   (Belgium)

^e UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; B7 ANTIGEN; CD11B ANTIGEN; CD45 ANTIGEN; CD86 ANTIGEN; CELL SURFACE MARKER; CHEMOKINE RECEPTOR CCR3; CXCL11 CHEMOKINE; CXCL9 CHEMOKINE; DIFFERENTIATION ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLYCOPROTEIN P 15095; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; LY 6C ANTIGEN; LY 6G ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; NITRIC OXIDE; PARVOVIRUS VECTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; TUMOR NECROSIS FACTOR ALPHA;

ADENO ASSOCIATED VIRUS; ADOPTIVE TRANSFER; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL LABELING; CHRONIC DISEASE; CONGENIC STRAIN; CONTROLLED STUDY; DENDRITIC CELL; ENZYME IMMUNOASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; KNOCKOUT MOUSE; LIVER CELL; LYMPH NODE; MONOCYTE; MOUSE; NAGANA; NONHUMAN; PATHOGENICITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; TISSUE INJURY; TRYPANOSOMA BRUCEI; VIRAL GENE DELIVERY SYSTEM; AFRICAN TRYPANOSOMIASIS; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL LINE; CELLULAR IMMUNITY; DRUG ANTAGONISM; ENZYMOLOGY; GENE VECTOR; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; MOUSE MUTANT; PARASITEMIA; PATHOLOGY; PHYSIOLOGY;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; DENDRITIC CELLS; DEPENDOVIRUS; FEMALE; GENETIC VECTORS; IMMUNITY, CELLULAR; IMMUNOPHENOTYPING; INTERLEUKIN-10; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MONOCYTES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PARASITEMIA; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 60549106289     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.182.2.1107     Document Type: Article

References (43)

1. Dent, L. A. 2002. For better or worse: common determinants influencing health and disease in parasitic infections, asthma and reproductive biology. J. Reprod. Immunol. 57: 255-272.
2. Sternberg, J. M. 2004. Human African trypanosomiasis: clinical presentation and immune response. Parasite Immunol. 26: 469-476.
3. Naessens, J. 2006. Bovine trypanotolerance: a natural ability to prevent severe anaemia and haemophagocytic syndrome? Int. J. Parasitol. 36: 521-528.
4. Drennan, M. B., B. Stijlemans, J. Van den Abbeele, V. J. Quesniaux, M. Barkhuizen, F. Brombacher, P. De Baetselier, B. Ryffel, and S. Magez. 2005. The induction of a type 1 immune response following a Trypanosoma brucei infection is MyD88 dependent. J. Immunol. 175: 2501-2509.
5. Hertz, C. J., H. Filutowicz, and J. M. Mansfield. 1998. Resistance to the African trypanosomes is IFN-γ dependent. J. Immunol. 161: 6775-6783.
6. Magez, S., M. Geuskens, A. Beschin, H. del Favero, H. Verschueren, R. Lucas, E. Pays, and P. de Baetselier. 1997. Specific uptake of tumor necrosis factor-α is involved in growth control of Trypanosoma brucei. J. Cell Biol. 137: 715-727.
7. Magez, S., M. Radwanska, A. Beschin, K. Sekikawa, and P. De Baetselier. 1999. Tumor necrosis factor α is a key mediator in the regulation of experimental Trypanosoma brucei infections. Infect. Immun. 67: 3128-3132.
8. Hertz, C. J., and J. M. Mansfield. 1999. IFN-γ-dependent nitric oxide production is not linked to resistance in experimental African trypanosomiasis. Cell. Immunol. 192: 24-32.
9. Namangala, B., W. Noel, P. De Baetselier, L. Brys, and A. Beschin. 2001. Relative contribution of interferon-γ and interleukin-10 to resistance to murine African trypanosomosis. J. Infect. Dis. 183: 1794-1800.
10. Stijlemans, B., T. N. Baral, M. Guilliams, L. Brys, J. Korf, M. Drennan, J. Van Den Abbeele, P. De Baetselier, and S. Magez. 2007. A glycosylphosphatidylinositol-based treatment alleviates trypanosomiasis- associated immunopathology. J. Immunol. 179: 4003-4014.
11. + T cells mediates early mortality in highly susceptible mice. J. Immunol. 176: 1724-1732.
12. Shi, M., W. Pan, and H. Tabel. 2003. Experimental African trypanosomiasis: IFN-γ mediates early mortality. Eur. J. Immunol. 33: 108-118.
13. Namangala, B., P. De Baetselier, L. Brys, B. Stijlemans, W. Noel, E. Pays, M. Carrington, and A. Beschin. 2000. Attenuation of Trypanosoma brucei is associated with reduced immunosuppression and concomitant production of Th2 lymphokines. J. Infect. Dis. 181: 1110-1120.
14. Guilliams, M., G. Oldenhove, W. Noel, M. Herin, L. Brys, P. Loi, V. Flamand, M. Moser, P. De Baetselier, and A. Beschin. 2007. African trypanosomiasis: naturally occurring regulatory T cells favor trypanotolerance by limiting pathology associated with sustained type 1 inflammation. J. Immunol. 179: 2748-2757.
15. Guilliams, M., T. Bosschaerts, M. Hérin, T. Hünig, P. Loi, V. Flamand, P. De Baetselier, and A. Beschin. 2008. Experimental expansion of regulatory T cells increases resistance to African trypanosomiasis. J. Infect. Dis. 198: 781-791.
16. Bosschaerts, T., M. Guilliams, W. Noel, M. Hérin, R. F. Burk, K. E. Hill, L. Brys, G. Raes, G. Hassanzadeh Ghassabeh, P. De Baetselier, and A. Beschin. 2008. Alternatively activated myeloid cells limit pathogenicity associated with African trypanosomiasis through the IL-10 inducible gene selenoprotein P. J. Immunol. 180: 6168-6175.
17. Namangala, B., P. De Baetselier, W. Noel, L. Brys, and A. Beschin. 2001. Alternative versus classical macrophage activation during experimental African trypanosomosis. J. Leukocyte Biol. 69: 387-396.
18. Lanham, S. M., and D. G. Godfrey. 1970. Isolation of salivarian trypanosomes from man and other mammals using DEAE-cellulose. Exp. Parasitol. 28: 521-534.
19. Gao, G. P., M. R. Alvira, L. Wang, R. Calcedo, J. Johnston, and J. M. Wilson. 2002. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. USA 99: 11854-11859.
20. Vandendriessche, T., L. Thorrez, A. Acosta-Sanchez, I. Petrus, L. Wang, L. Ma, L. DE Waele, Y. Iwasaki, V. Gillijns, J. M. Wilson, D. Collen, and M. K. Chuah. 2007. Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapy. J. Thromb. Haemost. 5: 16-24.
21. Miao, C. H., K. Ohashi, G. A. Patijn, L. Meuse, X. Ye, A. R. Thompson, and M. A. Kay. 2000. Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro. Mol. Ther. 1: 522-532.
22. Ghassabeh, G. H., P. De Baetselier, L. Brys, W. Noel, J. A. Van Ginderachter, S. Meerschaut, A. Beschin, F. Brombacher, and G. Raes. 2006. Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo in different pathologic conditions. Blood 108: 575-583.
23. Geissmann, F., S. Jung, and D. R. Littman. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82.
24. Gordon, S., and P. R. Taylor. 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5: 953-964.
25. Serbina, N. V., T. P. Salazar-Mather, C. A. Biron, W. A. Kuziel, and E. G. Pamer. 2003. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19: 59-70.
26. + dendritic cells during Brucella melitensis infection. J. Immunol. 178: 5182-5191.
27. Liu, K., C. Waskow, X. Liu, K. Yao, J. Hoh, and M. Nussenzweig. 2007. Origin of dendritic cells in peripheral lymphoid organs of mice. Nat. Immunol. 8: 578-583.
28. Krutzik, S. R., B. Tan, H. Li, M. T. Ochoa, P. T. Liu, S. E. Sharfstein, T. G. Graeber, P. A. Sieling, Y. J. Liu, T. H. Rea, et al. 2005. TLR activation triggers the rapid differentiation of monocytes into macrophages and dendritic cells. Nat. Med. 11: 653-660.
29. Lowes, M. A., F. Chamian, M. V. Abello, J. Fuentes-Duculan, S. L. Lin, R. Nussbaum, I. Novitskaya, H. Carbonaro, I. Cardinale, T. Kikuchi, et al. 2005. Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc. Natl. Acad. Sci. USA 102: 19057-19062.
30. Noel, W., G. Hassanzadeh, G. Raes, B. Namangala, I. Daems, L. Brys, F. Brombacher, P. De Baetselier, and A. Beschin. 2002. Infection stage-dependent modulation of macrophage activation in Trypanosoma congolense-resistant and -susceptible mice. Infect. Immun. 70: 6180-6187.
31. Schleifer, K. W., and J. M. Mansfield. 1993. Suppressor macrophages in African trypanosomiasis inhibit T cell proliferative responses by nitric oxide and prostaglandins. J. Immunol. 151: 5492-5503.
32. Buelens, C., V. Verhasselt, D. De Groote, K. Thielemans, M. Goldman, and F. Willems. 1997. Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/ macrophage-colony-stimulating factor. Eur. J. Immunol. 27: 756-762.
33. Allavena, P., L. Piemonti, D. Longoni, S. Bernasconi, A. Stoppacciaro, L. Ruco, and A. Mantovani. 1998. IL-10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages. Eur. J. Immunol. 28: 359-369.
34. + blood monocytes, promotes the differentiation to mature macrophages and stimulates endocytosis of FITC-dextran. Adv. Exp. Med. Biol. 417: 323-327.
35. Buelens, C., F. Willems, A. Delvaux, G. Pierard, J. P. Delville, T. Velu, and M. Goldman. 1995. Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells. Eur. J. Immunol. 25: 2668-2672.
36. De Smedt, T., M. Van Mechelen, G. De Becker, J. Urbain, O. Leo, and M. Moser. 1997. Effect of interleukin-10 on dendritic cell maturation and function. Eur. J. Immunol. 27: 1229-1235.
37. Corinti, S., C. Albanesi, A. la Sala, S. Pastore, and G. Girolomoni. 2001. Regulatory activity of autocrine IL-10 on dendritic cell functions. J. Immunol. 166: 4312-4318.
38. Schoenbein, C., W. D. Docke, K. Wolk, G. Belbe, C. Hoflich, M. Jung, G. Grutz, W. Sterry, H. D. Volk, K. Asadullah, and R. Sabat. 2008. Long-term interleukin-10 presence induces the development of a novel, monocyte-derived cell type. Clin. Exp. Immunol. 151: 306-316.
39. Gasperini, S., M. Marchi, F. Calzetti, C. Laudanna, L. Vicentini, H. Olsen, M. Murphy, F. Liao, J. Farber, and M. A. Cassatella. 1999. Gene expression and production of the monokine induced by IFN-γ (MIG), IFN-inducible T cell α chemoattractant (I-TAC), and IFN-γ-inducible protein-10 (IP-10) chemokines by human neutrophils. J. Immunol. 162: 4928-4937.
40. Taylor, K. A. 1998. Immune responses of cattle to African trypanosomes: protective or pathogenic? Int. J. Parasitol. 28: 219-240.
41. Kennedy, P. G. 2004. Human African trypanosomiasis of the CNS: current issues and challenges. J. Clin. Invest. 113: 496-504.
42. Ballabh, P., A. Braun, and M. Nedergaard. 2004. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis. 16: 1-13.
43. Sternberg, J. M., J. Rodgers, B. Bradley, L. Maclean, M. Murray, and P. G. Kennedy. 2005. Meningoencephalitic African trypanosomiasis: brain IL-10 and IL-6 are associated with protection from neuro-inflammatory pathology. J. Neuroimmunol. 167: 81-89.